K Prabhash Selected Research

K Prabhash Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 01/2006
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2017 - 12/2010
9	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2014
8	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2013
6	Carcinoma (Carcinomatosis) 01/2019 - 01/2013
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 07/2013
4	Infections 10/2014 - 10/2009
3	Adenocarcinoma of Lung 01/2017 - 01/2015
3	Febrile Neutropenia 04/2016 - 01/2013
2	Esophageal Neoplasms (Esophageal Cancer) 10/2022 - 04/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 09/2016
2	Brain Neoplasms (Brain Tumor) 01/2018 - 12/2010
2	Adenocarcinoma 01/2018 - 07/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017 - 04/2013
2	Disease Progression 09/2016 - 07/2013
2	Exanthema (Rash) 07/2016 - 01/2016
2	Mouth Neoplasms (Oral Cancer) 12/2015 - 04/2013
2	Leukemia 01/2011 - 01/2009
2	Acute Promyelocytic Leukemia 01/2011 - 01/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2008 - 07/2007
2	Lymphoma (Lymphomas) 07/2008 - 07/2007
1	Esophageal Squamous Cell Carcinoma 10/2022
1	Seminoma 01/2021
1	Nasopharyngeal Carcinoma 12/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Sensorineural Hearing Loss 04/2017
1	Thoracic Diseases 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Vomiting 07/2016
1	Mucositis 07/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2016
1	Diarrhea 01/2016
1	Pulmonary Atelectasis 07/2015
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 07/2014
1	Laryngeal Neoplasms (Laryngeal Cancer) 04/2014
1	Respiratory Sounds (Crackle) 04/2014
1	Thymoma (Thymic Carcinoma) 04/2014

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 01/2017 - 07/2013
6	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2013
5	Pharmaceutical PreparationsIBA 01/2017 - 07/2008
4	PlatinumIBA 01/2021 - 04/2013
4	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 01/2016
4	Anaplastic Lymphoma KinaseIBA 01/2017 - 04/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 04/2013
4	Docetaxel (Taxotere)FDA Link 09/2016 - 02/2004
3	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 07/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2014 - 10/2009
2	NivolumabIBA 01/2021 - 01/2017
2	taxaneIBA 12/2019 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 01/2015
2	CrizotinibIBA 04/2017 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 04/2013
2	Sunitinib (Sutent)FDA Link 01/2016 - 07/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 04/2013
2	Retinoic Acid Receptor alphaIBA 01/2011 - 01/2009
2	Ceftazidime (Fortum)FDA LinkGeneric 04/2010 - 10/2009
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 04/2010 - 10/2009
1	nimotuzumabIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2018
1	QuartzIBA 01/2018
1	CreatinineIBA 04/2017
1	Carboplatin (JM8)FDA LinkGeneric 04/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	ceritinibIBA 01/2017
1	ParaffinIBA 01/2017
1	pazopanib FDA Link 10/2016
1	GoldIBA 10/2016
1	Sorafenib (BAY 43-9006)FDA Link 07/2016
1	AntiemeticsIBA 07/2016
1	CytokinesIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015
1	Gefitinib (Iressa)FDA Link 10/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014
1	Hemoglobins (Hemoglobin)IBA 10/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2014
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2014
1	cabazitaxel FDA Link 07/2014

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 10/2022 - 07/2007
16	Therapeutics 10/2022 - 07/2007
8	Radiotherapy 01/2022 - 12/2010
7	Neoadjuvant Therapy 01/2018 - 01/2013
6	Induction Chemotherapy 12/2019 - 01/2013
3	Chemoradiotherapy 10/2022 - 07/2015
1	Image-Guided Radiotherapy 01/2022
1	Immunotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Palliative Care (Palliative Therapy) 10/2015